Safety of Closed-Loop Insulin Delivery System

October 24, 2016
Bobby Lazzara, MD

Dr. Bobby Lazzara reviews the safety of a hybrid closed-loop insulin delivery system for patients with type 1 diabetes in a real-world setting.

Can a hybrid closed-loop insulin delivery system offer safe and effective treatment for patients with type 1 diabetes in a real-world setting? In this Medical News Minute, developed exclusively for Endocrinology Network, Dr. Bobby Lazzara reports on a study of the MiniMed 670G.